S SYNERK Trademark

Trademark Overview


On Wednesday, October 9, 2019, a trademark application was filed for S SYNERK with the United States Patent and Trademark Office. The USPTO has given the S SYNERK trademark a serial number of 88647577. The federal status of this trademark filing is REGISTERED as of Tuesday, August 25, 2020. This trademark is owned by SynerK, Inc.. The S SYNERK trademark is filed in the Pharmaceutical Products category with the following description:

Medical therapeutic preparations, namely, biologically active antisense DNA or RNA compounds; pharmaceuticals and vaccine adjuvants for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, rare diseases, asthma or allergies, cancer, auto immune diseases and disorders; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
s synerk

General Information


Serial Number88647577
Word MarkS SYNERK
Filing DateWednesday, October 9, 2019
Status700 - REGISTERED
Status DateTuesday, August 25, 2020
Registration Number6134380
Registration DateTuesday, August 25, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 9, 2020

Trademark Statements


Description of MarkThe mark consists of a double helix DNA section wherein the shape of said section represents the shape of the letter 'S'. The left half of the double helix is in green and the right half of the double helix is in blue. Below the double helix DNA section, the literal element ("SynerK") appears in black text, with the letters 'S' and 'K' in upper-case and the remainder in lower-case. The white background is shown for contrast and is not claimed as part of the mark.
Goods and ServicesMedical therapeutic preparations, namely, biologically active antisense DNA or RNA compounds; pharmaceuticals and vaccine adjuvants for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, rare diseases, asthma or allergies, cancer, auto immune diseases and disorders; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
Indication of Colors claimedThe color(s) green, blue, and black is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 15, 2019
Primary Code005
First Use Anywhere DateTuesday, October 23, 2018
First Use In Commerce DateTuesday, October 23, 2018

Trademark Owner History


Party NameSynerK, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressConcord, MA 01742

Party NameSynerK, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressConcord, MA 01742

Party NameSynerK, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressConcord, MA 01742

Trademark Events


Event DateEvent Description
Saturday, October 12, 2019NEW APPLICATION ENTERED
Tuesday, October 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 15, 2020NON-FINAL ACTION WRITTEN
Wednesday, January 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 14, 2020ASSIGNED TO EXAMINER
Wednesday, January 15, 2020NON-FINAL ACTION E-MAILED
Monday, May 4, 2020ASSIGNED TO LIE
Tuesday, May 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 20, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 9, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 9, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 25, 2020REGISTERED-PRINCIPAL REGISTER
Monday, August 25, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED